Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
- 1Anthony Nolan Research Institute, Royal Free Hospital, London, United Kingdom
- 2Cancer Institute, University College London, London, United Kingdom
- 3Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
A Corrigendum on
Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma
by Cox, S. T., Danby, R., Hernandez, D., Laza-Briviesca, R., Pearson, H., Madrigal, J. A., et al. (2018). Front. Immunol. 9:1282. doi: 10.3389/fimmu.2018.01282
Raquel Laza-Briviesca and Hayley Pearson were not included as authors in the published article. The corrected Author Contributions Statement appears below.
Author Contributions
SC, AS, and JM conceived and designed the study. SC designed and performed experiments, acquired data, performed statistical analysis, interpreted the data, and wrote the manuscript. DH and RD contributed to the administrative, technical, or material support of the study and critically revised the manuscript for important intellectual content. RL-B and HP carried out extensive assay procedures and results analysis. All authors approved the final version of the manuscript.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: NK cell, pregnancy, tolerance, NKG2D, ligand, luciferase, MICA, ULBP1
Citation: Cox ST, Danby R, Hernandez D, Laza-Briviesca R, Pearson H, Madrigal JA and Saudemont A (2020) Corrigendum: Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma. Front. Immunol. 11:87. doi: 10.3389/fimmu.2020.00087
Received: 07 January 2020; Accepted: 13 January 2020;
Published: 04 February 2020.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2020 Cox, Danby, Hernandez, Laza-Briviesca, Pearson, Madrigal and Saudemont. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Steven T. Cox, c3RldmVuLmNveCYjeDAwMDQwO2FudGhvbnlub2xhbi5vcmc=
†Present address: Aurore Saudemont, Medicines Research Centre, GSK, Stevenage, United Kingdom